In terms of hashish, most nonetheless conjure up the photographs of it being smoked. However a forward-thinking firm known as Speedy Dose Therapeutics Corp. (RDT) (CSE: DOSE, OTC Pink: RDTCF, Discussion board) has developed a proprietary, patent-pending system to assist assist the quickest rising phase of the medical and adult-use hashish market, smoke-free alternate options. The edibles phase of this market alone is predicted to document a 22.5% CAGR and dominate $9.2 billion of the $11.8 billion market.
RDT is a Canadian biotechnology firm that develops disruptive proprietary drug supply applied sciences, together with the QuickStrip™, that are designed to enhance the patron’s expertise. Shaped due to a acknowledged must simplify and improve drug supply, the corporate supplies product innovation, manufacturing, and session to the pharmaceutical, nutraceutical and hashish industries.
The principle ingredient in all smoke-free hashish merchandise, together with edibles, vape cartridges, capsules, dabs, and tinctures, is what known as distillate, which has no taste or aroma of hashish flower. Distillate is often extracted from hashish crops grown indoors or open air, utilizing a wide range of strategies to try to purify the fabric and take away any undesirable chemical compounds or residues which may be dangerous to the patron.
As the necessity for dependable THC distillate will increase to provide the demand for smoke-free merchandise, there are issues over provide shortages. That is the place Speedy Dose Therapeutics steps in.
The Burlington, Ontario-based firm, along with its analysis companions at Hamilton’s McMaster College, have developed a novel course of to fill the void of the distillate shortages utilizing Speedy Dose Therapeutics expertise to create Ultrapure THC™ or U-THC™ for brief.
This novel and proprietary course of that selectively transforms CBD from hemp into Ultrapure THC distillate in mass portions allows the cost-effective manufacturing of Ultrapure THC for use in each the grownup and medical-use hashish markets in addition to the potential to allow pharmaceutical corporations to enter the market with a constant provide of uncooked materials or lively pharmaceutical elements (APIs) that can be utilized to supply pharma grade merchandise.
And right here’s the kicker. RDT’s U-THC precision expertise can reliably produce as much as 100 to 300 kilograms of constant Ultrapure THC distillate per day from pure CBD isolate derived from hemp when in comparison with different corporations which might be restricted by the hashish they’ll develop each few months.
Speedy Dose’s newest growth is a patent-pending ultra-clean course of which achieves U-THC with zero use of acids, heavy metals, reactive supplies, or poisonous substances, in contrast to anybody within the distillate trade. Moreover, RDT’s course of is essentially the most cost-effective at the moment in the marketplace.
What’s extra, 99% of the CBD isolate is then transformed into Ultrapure THC with a selective Delta 9 or Delta 8 final result. This allows producers to scale up their manufacturing to supply merchandise shoppers need.
In tandem with this, final 12 months Speedy Dose Therapeutics entered into an settlement with ESJ Enterprises, a subsidiary of Isolera Extracts, the place the corporate is producing Ultrapure THC distillate utilizing this proprietary transformation expertise.
ESJ has labored with Speedy Dose Therapeutics over the previous 12 months to construct a scalable course of and facility that can be capable to produce at the very least 100 kilograms of U-THC distillate per day.
Isolera Extracts and ESJ Enterprises CEO Jack Tatum, commented:
“The mixed effort of RDT and ESJ has created a novel strategy to resolve the huge and steady provide points dealing with producers in most states. We’re happy with the working relationship and the joint deal with producing Ultrapure THC merchandise with the intent to alter the THC distillate market dynamics globally. The ESJ group has the gear and confirmed expertise to ship on its contracts and high quality promise and can proceed to develop manufacturing.”
Immediately, Speedy Dose Therapeutics is an organization that works diligently to offer revolutionary, proprietary drug supply applied sciences aimed toward enhancing the patron expertise and affected person outcomes.
Throughout the hashish trade, the corporate’s merchandise embody its state-of-the-art QuickStrip™ proprietary hashish supply expertise which is gaining recognition throughout the market by means of non-public label agreements with Thrive and Aphria with greater than one million strips having been produced so far. Moreover, RDT is anticipating to obtain its Well being Canada hashish gross sales license that can see RDT branded QuickStrip and QuickSip™ merchandise distributed in Canadian retail places by means of a distribution settlement with CannMart, a subsidiary of Namaste Applied sciences.
(Click on picture to enlarge)
Due to its ground-breaking merchandise, buyers have definitely taken be aware of RDT. Shares of the corporate have skyrocketed 100% year-to-date, whereas year-over-year the corporate’s share value has risen a blistering practically two-fold.
Given the funding metrics as is, and regardless of its latest share value rise, DOSE nonetheless seems to be a cut price purchase. As its U-THC distillate expertise is predicted to take off, buyers will certainly be eager to see what Speedy Dose Therapeutics will do subsequent.
For extra data, go to www.rapid-dose.com.
FULL DISCLOSURE: It is a paid article produced by Stockhouse Publishing.